Ameriprise
ARCT icon

Ameriprise’s Arcturus Therapeutics ARCT Stock Holding History

Ameriprise’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Buy
+65,282
New +$515K ﹤0.01% 3695
2025
Q3 		– Sell
-72,252
Closed -$940K – 4061
2025
Q2 		$940K Buy
72,252
+57,152
+378% +$676K ﹤0.01% 3293
2025
Q1 		$160K Sell
15,100
-3,513
-19% -$55.8K ﹤0.01% 3822
2024
Q4 		$316K Buy
18,613
+883
+5% +$16.6K ﹤0.01% 3701
2024
Q3 		$412K Sell
17,730
-1,460
-8% -$31.2K ﹤0.01% 3554
2024
Q2 		$467K Buy
19,190
+1,305
+7% +$39.6K ﹤0.01% 3439
2024
Q1 		$604K Sell
17,885
-7,343
-29% -$260K ﹤0.01% 3354
2023
Q4 		$795K Buy
25,228
+16,443
+187% +$391K ﹤0.01% 3286
2023
Q3 		$224K Sell
8,785
-138
-2% -$4.25K ﹤0.01% 3670
2023
Q2 		$256K Buy
8,923
+115
+1% +$3.13K ﹤0.01% 3653
2023
Q1 		$211K Sell
8,808
-6,722
-43% -$121K ﹤0.01% 3717
2022
Q4 		$263K Buy
15,530
+1,510
+11% +$26.3K ﹤0.01% 3634
2022
Q3 		$208K Buy
+14,020
New +$235K ﹤0.01% 3690
2021
Q4 		– Sell
-5,830
Closed -$279K – 3957
2021
Q3 		$279K Buy
+5,830
New +$261K ﹤0.01% 3600
2021
Q1 		– Sell
-9,559
Closed -$415K – 3836
2020
Q4 		$415K Sell
9,559
-46,765
-83% -$3.17M ﹤0.01% 3407
2020
Q3 		$2.42M Sell
56,324
-13,978
-20% -$694K ﹤0.01% 2559
2020
Q2 		$3.29M Buy
+70,302
New +$2.42M ﹤0.01% 2346

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ameriprise's ARCT Position: Q2 2026 in Review

Ameriprise opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 65,282 shares worth $439K. The stake represents ﹤0.01% of the portfolio and ranks #3695 among its holdings. This is a return to the name: Ameriprise previously reported a position in ARCT as recently as Q2 2025.

Ameriprise first reported a position in ARCT in Q2 2020 and has held it in 17 quarters since. The position peaked at $3.29M in Q2 2020. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Ameriprise held 65,282 shares of Arcturus Therapeutics worth $439K as of Q2 2026.
  • Arcturus Therapeutics was a new Ameriprise position in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3695 holding.
  • Ameriprise first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Ameriprise's Arcturus Therapeutics position peaked at $3.29M in Q2 2020.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.